mebudipine

Abstract A nanoemulsion drug delivery system was developed to increase the oral bioavailability of mebudipine as a calcium… Expand

Background: Myocardial infarction (MI) is the acute condition of necrosis in myocardium which occurs as a result of imbalance… Expand

In the present study, we investigated the effects of mebudipine and dibudipine, two new Ca(2+) channel blockers, on primary… Expand

The protective effect of two new L-type calcium-channel blockers, mebudipine and dibudipine on neurotoxic effects induced by… Expand

Mebudipine and dibudipine are two newly synthesized dihydropyridine (DHP) calcium channel blockers that have been shown to have… Expand

The prototype 1,4‐dihydropyridine (1,4‐DHP) nifedipine, indicated for the management of hypertension and angina pectoris, has… Expand

In previous studies, mebudipine, a newly synthesized dihydropyridine calcium channel blocker, showed a considerable vasoselective… Expand

Mebudipine and dibudipine are two new dihydropyridine (DHP) Ca2+ channel blockers that have been synthesized by Mahmoudian et al… Expand

Mebudipine and dibudipine are two new dihydropyridine calcium‐channel blockers that have been synthesized in our laboratory. In a… Expand

Dihydropyridine derivative calcium‐channel blockers are widely used in the therapy of hypertension, angina pectoris and other… Expand